GB1600915A - Phosphonium salts - Google Patents

Phosphonium salts Download PDF

Info

Publication number
GB1600915A
GB1600915A GB5961/80A GB596180A GB1600915A GB 1600915 A GB1600915 A GB 1600915A GB 5961/80 A GB5961/80 A GB 5961/80A GB 596180 A GB596180 A GB 596180A GB 1600915 A GB1600915 A GB 1600915A
Authority
GB
United Kingdom
Prior art keywords
tetramethyl
phosphonium salts
represent
ethyll
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5961/80A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1600915A publication Critical patent/GB1600915A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/38—Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/50—Halogenated unsaturated alcohols containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/792—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB5961/80A 1977-05-04 1978-05-03 Phosphonium salts Expired GB1600915A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77254A LU77254A1 (enExample) 1977-05-04 1977-05-04

Publications (1)

Publication Number Publication Date
GB1600915A true GB1600915A (en) 1981-10-21

Family

ID=19728555

Family Applications (2)

Application Number Title Priority Date Filing Date
GB5961/80A Expired GB1600915A (en) 1977-05-04 1978-05-03 Phosphonium salts
GB17478/78A Expired GB1600914A (en) 1977-05-04 1978-05-03 Polyene compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB17478/78A Expired GB1600914A (en) 1977-05-04 1978-05-03 Polyene compounds

Country Status (32)

Country Link
US (1) US4193931A (enExample)
JP (1) JPS53137940A (enExample)
AR (1) AR220704A1 (enExample)
AT (1) AT356647B (enExample)
AU (1) AU522598B2 (enExample)
BE (1) BE866651A (enExample)
BR (1) BR7802807A (enExample)
CA (1) CA1114830A (enExample)
CH (2) CH641755A5 (enExample)
CS (1) CS214853B2 (enExample)
CU (1) CU21105A (enExample)
DE (1) DE2819213A1 (enExample)
DK (1) DK155730C (enExample)
ES (2) ES469394A1 (enExample)
FI (1) FI66587C (enExample)
FR (1) FR2390428A1 (enExample)
GB (2) GB1600915A (enExample)
GR (1) GR74426B (enExample)
HU (1) HU183088B (enExample)
IE (1) IE46946B1 (enExample)
IL (2) IL54590A (enExample)
IT (1) IT1096278B (enExample)
LU (1) LU77254A1 (enExample)
MC (1) MC1193A1 (enExample)
MY (1) MY8500250A (enExample)
NL (1) NL7804773A (enExample)
NO (1) NO148290C (enExample)
NZ (1) NZ187114A (enExample)
PH (1) PH14216A (enExample)
PT (1) PT67988B (enExample)
SE (1) SE436644B (enExample)
ZA (1) ZA782415B (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216312A (en) 1978-08-24 1980-08-05 Hoffmann-La Roche Inc. Furyl substituted polyenes
FI67386C (fi) * 1979-06-21 1985-03-11 Hoffmann La Roche Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sockerderivat
CH651007A5 (de) * 1982-06-24 1985-08-30 Hoffmann La Roche Polyenverbindungen.
DK158947C (da) * 1982-07-06 1991-01-21 Hoffmann La Roche Tetrahydronaphthalin-,benzofuran- og benzothiophenderivater, fremstilling og anvendelse deraf samt rodenticid indeholdende saadanne derivater
US4529600A (en) * 1982-09-09 1985-07-16 Sri International Pentadeuterioretinoids
US4439614A (en) * 1982-09-22 1984-03-27 Sri International 5,6-Methano-5,6-dihydroretinoids
US4464389A (en) * 1982-10-20 1984-08-07 Sri International Esters of retinoic acid and pentaerythritol and monobenzal acetals thereof
US4539154A (en) * 1983-06-15 1985-09-03 Hoffmann-La Roche Inc. Polyene compounds
CH661516A5 (de) * 1983-12-08 1987-07-31 Hoffmann La Roche Phenylnonatetraenoylzuckerderivate.
FR2569689B1 (fr) * 1984-09-05 1990-11-16 Oreal Nouveaux derives du benzonorbornene, leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
FR2580277B1 (fr) * 1985-04-15 1988-06-10 Oreal Nouveaux derives naphtaleniques a action retinoique, le ur procede de preparation et compositions medicamenteuse et cosmetique les contenant
US5030765A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
ZW7487A1 (en) * 1986-05-23 1987-12-16 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
US5030764A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
AT388728B (de) * 1987-03-17 1989-08-25 Hoffmann La Roche Neue tetrahydronaphthalin- und indanderivate
US5250562A (en) * 1988-02-24 1993-10-05 Hoffmann-La Roche Inc. Stilbene derivatives
US5248696A (en) * 1991-04-18 1993-09-28 World Research Institute For Science And Technology, Inc. Composition and method for treating tumors
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
CA2129773C (en) * 1993-09-02 2007-05-01 Michael Klaus Aromatic carboxylic acid derivatives
FR2719041B1 (fr) * 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
MX9704878A (es) * 1994-12-30 1997-11-29 Ligand Pharm Inc Nuevos compuestos retinoides trienoicos y metodos de uso.
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
AU726450B2 (en) 1995-10-06 2000-11-09 Ligand Pharmaceuticals Incorporated Dimer-selective RXR modulators and methods for their use
US6112489A (en) * 1995-12-12 2000-09-05 Monotech International, Inc. Monocoque concrete structures
WO1998007716A2 (en) * 1996-08-23 1998-02-26 The Board Of Regents For Oklahoma State University Heteroarotinoids-anticancer agents with receptor specificity and tgase activity
FR2752837B1 (fr) * 1996-09-02 1999-11-12 Cird Galderma Nouveaux composes modulateurs des recepteurs hormonaux, les compositions les comprenant et leur utilisation en therapie
WO1999005161A1 (en) * 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR
FR2768731B1 (fr) 1997-09-25 1999-12-10 Cird Galderma Derives insatures en position -4 du 6-tert-butyl-1,1- dimethylindane et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique
US6534545B1 (en) 1997-09-25 2003-03-18 Galderma Research & Development Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and cosmetics
CA2334545A1 (en) * 1998-06-12 1999-12-16 Ligand Pharmaceuticals Incorporated Treatment of anti-estrogen resistant breast cancer using rxr modulators
MXPA02002032A (es) * 1999-08-27 2003-05-19 Ligand Pharm Inc Compuestos moduladores del receptor de androgeno y metodos.
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
EP1212322A2 (en) 1999-08-27 2002-06-12 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
US6593493B1 (en) 1999-09-14 2003-07-15 Ligand Pharmaceuticals, Inc. RXR modulators with improved pharmacologic profile
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) * 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US6586460B1 (en) 2001-04-02 2003-07-01 The Board Of Regents For Oklahoma State University Heteroarotinoids containing urea or thiourea linker
EP1511477A4 (en) * 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS
JP2006508986A (ja) * 2002-11-20 2006-03-16 エルラント ゲネ セラペウチクス エルエルシー ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法
US9050310B2 (en) * 2004-06-25 2015-06-09 Minas Theodore Coroneo Treatment of ocular lesions
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US20060204474A1 (en) * 2005-02-25 2006-09-14 Coroneo Minas T Treatment of epithelial layer lesions
WO2012076842A1 (en) * 2010-12-09 2012-06-14 University Of Durham Synthetic retinoids for control of cell differentiation
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas
US10980725B2 (en) * 2017-09-28 2021-04-20 Johnson & Johnson Consumer Inc. Cosmetic compositions and method of treating the skin
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
BR112021000724A2 (pt) * 2018-07-27 2021-04-13 Johnson & Johnson Surgical Vision, Inc. Composições e métodos para tratar os olhos
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452085A (en) * 1966-02-11 1969-06-24 Carbo Erba Spa Alpha-(5-indanyl)-butyric acid
US3781314A (en) * 1971-07-14 1973-12-25 Hoffmann La Roche Polyene compounds
BE793108A (fr) * 1971-12-22 1973-06-21 Hoffmann La Roche Derives polyeniques
FR2235679B1 (enExample) * 1973-07-02 1978-07-21 Takeda Chemical Industries Ltd
CH582668A5 (enExample) * 1973-08-10 1976-12-15 Hoffmann La Roche
CH585709A5 (enExample) * 1973-08-24 1977-03-15 Hoffmann La Roche
CH592598A5 (enExample) * 1973-10-30 1977-10-31 Hexachimie
AR206619A1 (es) * 1974-02-07 1976-08-06 Hexachimie Procedimiento para peparar acidos 5-indanilaceticos
FR2276035A1 (fr) * 1974-06-28 1976-01-23 Lipha Nouveaux derives de l'indane
JPS51125235A (en) * 1974-09-26 1976-11-01 Hoffmann La Roche Preparation of polyene compounds
US4054589A (en) * 1974-09-26 1977-10-18 Hoffmann-La Roche Inc. Novel 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraene esters

Also Published As

Publication number Publication date
AU522598B2 (en) 1982-06-17
GR74426B (enExample) 1984-06-28
GB1600914A (en) 1981-10-21
AR220704A1 (es) 1980-11-28
MY8500250A (en) 1985-12-31
LU77254A1 (enExample) 1979-01-18
HU183088B (en) 1984-04-28
BR7802807A (pt) 1979-01-02
CS214853B2 (en) 1982-06-25
FI66587C (fi) 1984-11-12
IL54590A (en) 1982-02-28
IT1096278B (it) 1985-08-26
ES469394A1 (es) 1979-02-01
IE46946B1 (en) 1983-11-16
SE436644B (sv) 1985-01-14
NO148290C (no) 1983-09-14
FR2390428B1 (enExample) 1983-03-04
JPS6332777B2 (enExample) 1988-07-01
PT67988A (en) 1978-06-01
NO781586L (no) 1978-11-07
MC1193A1 (fr) 1979-02-23
DK195378A (da) 1978-11-05
PT67988B (en) 1980-05-05
FI781227A7 (fi) 1978-11-05
CH641755A5 (de) 1984-03-15
NO148290B (no) 1983-06-06
FI66587B (fi) 1984-07-31
ATA320478A (de) 1979-10-15
IE780864L (en) 1978-11-04
DK155730C (da) 1989-10-02
ES475240A1 (es) 1979-05-16
IT7823003A0 (it) 1978-05-04
US4193931A (en) 1980-03-18
DE2819213C2 (enExample) 1987-09-24
SE7805136L (sv) 1978-11-05
NL7804773A (nl) 1978-11-07
PH14216A (en) 1981-04-02
DE2819213A1 (de) 1978-11-16
NZ187114A (en) 1980-11-14
AU3576278A (en) 1979-11-08
BE866651A (fr) 1978-11-03
IL61697A0 (en) 1981-01-30
CA1114830A (en) 1981-12-22
JPS53137940A (en) 1978-12-01
CU21105A (es) 1981-12-04
FR2390428A1 (fr) 1978-12-08
AT356647B (de) 1980-05-12
DK155730B (da) 1989-05-08
ZA782415B (en) 1979-04-25
IL54590A0 (en) 1978-07-31
CH642380A5 (de) 1984-04-13

Similar Documents

Publication Publication Date Title
Ley et al. Microbial oxidation in synthesis: preparation of myo-inositol phosphates and related cyclitol derivatives from benzene
CA1114830A (en) Polyene compounds
Hortmann et al. Thiabenzenes. III. Synthesis and properties of thiabenzene 1-oxides
NZ206919A (en) Analogues of mevalonolactone, derivatives thereof and pharmaceutical compositions
US2842599A (en) Carotenoids and intermediates therefor
Billington et al. The total synthesis of myo-inositol phosphates via myo-inositol orthoformate
Schweizer et al. Reactions of phosphorus compounds. XXI. Preparation and reactions of 5-benzoyl-2, 2, 2, 5-tetraphenyl-1-oxa-2-phospholane
Puterbaugh et al. Isolation of Intermediate Alkali Salt in ortho-Substitution Rearrangement of Benzyltrimethylammonium Ion as Benzophenone Adduct
Marr et al. Unsymmetrically disubstituted ferrocenes. Part VIII. Synthesis and reactivity of some 2-substituted ferrocenylphosphines
Hata et al. New phosphorylating reagent. I. Preparation of alkyl dihydrogen phosphates by means of 2-chloromethyl-4-nitrophenyl phosphorodichloridate
US3032589A (en) Method of preparing organophosphorus oxides
NO874759L (no) Fremgangsmaate til fremstilling av purin-9-yl-alkylenoksymetylfosfonsyrer.
Klunder et al. Chemistry of strained polycyclic compounds—V: The stereospecific cationic cage expansion reaction of 4-homocubane carbinols to 1, 3-bishomocubane bridgehead alcohols
Benjamin et al. Preparation of boron cations by hydride ion abstraction
Gurskii et al. Organoboron compounds: CDXCV. A regioselective reaction of hydride abstraction in the series of 3-alkyl-3-borabicyclo [4.3. 1] decane ate-complexes
IE46947B1 (en) Phosphonium salts
US4082781A (en) Synthesis of 2-alkanoylamino-4-nitrophenyl phosphorylcholine-hydroxide
JPS5828877B2 (ja) 新規２，６−ジメトキシ−４−置換フエニル・ジ置換ホスフエイト類
SU862828A3 (ru) Способ получени 9-/2-оксиэтоксиметил/-гуанинфосфатов
SU677660A3 (ru) Способ получени производных хроманона
US4126639A (en) Process for 11a-dehalogenation of 11a-halotetracyclines
Nifantyev et al. SYNTHESIS OF 1, 2-O-ISOPROPYLIDENE GLYCERO-THIOLO-(DITHIOLO)-PHOSPHOHOMOCHOLINES. A NEW THION-THIOL ISOMERIZATION OF ALKYLENE PHOSPHOROTHIOATES
US3878194A (en) Novel phosphorylated phosphonium ylids
US2881218A (en) 4-chloro-5, 7-dihydroxy-2-methyl-1-indanone
SU451239A3 (ru) Способ получени 3-кетостероидов

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
704A Declaration that licence is not available as of right for an excepted use (par. 4a/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930503